(May 26, 2022, 1:55 PM EDT) -- SAN FRANCISCO — A woman filed a putative class action on May 18 in a California federal court accusing four companies of manufacturing, marketing and selling at a premium over-the-counter drugs advertised as “rapid release” that in fact dissolve no faster and possibly more slowly than cheaper forms of the drugs, in violation of California’s unfair competition law (UCL) and other statutes....